Presentation anxiety is common across community, college, adolescent, and laboratory research. The available findings range from fears of going blank or appearing visibly anxious to measured relationships between self-reported anxiety, speech performance, and physiological responses. The studies below report different populations and measures, so their percentages should not be treated as one combined estimate.
Contents
- How common is presentation anxiety?
- When does public-speaking fear begin?
- What do people fear during a presentation?
- How much does anxiety affect daily life?
- What do college-student studies show?
- How is presentation anxiety measured?
- What do intervention studies report?
How common is presentation anxiety?
Several studies show that fear of speaking before others is widespread, although the reported rate depends on the sample, wording, and threshold used.
In Public-Speaking Fears in a Community Sample: Prevalence, Impact on Functioning, and Diagnostic Classification, one third of respondents reported excessive anxiety when speaking to a large audience. That broad finding describes a substantial community-sample experience, but it does not mean that every respondent met criteria for a disorder or experienced the same level of impairment.
A separate college-student study, Fear of Public Speaking: Perception of College Students and Correlates, found that 63.9% of undergraduates reported fear of public speaking. The study surveyed 1,135 undergraduates aged 17 to 58 years. In the same study, 89.3% wanted public-speaking classes included in their undergraduate program, suggesting that students recognized presentation skill development as a relevant educational need.
Research in Japan provides another population-specific estimate. Public speaking fears and their correlates among 17,615 Japanese adolescents noted public-speaking fears in 7.3% of the adolescents studied. This percentage applies to that adolescent sample and should not be directly compared with the college or community findings without accounting for the different populations and definitions.
Broader social-anxiety statistics provide context rather than a direct estimate of presentation anxiety. A review of the epidemiology and approaches to the treatment of social anxiety disorder reports a 1-year prevalence of 7% to 8% and a lifetime prevalence of 13% to 14% for social anxiety disorder. Social phobia reports a prevalence of 10% to 15% for social anxiety disorder and describes it as the most frequent anxiety disorder. These figures concern broader clinical categories, not presentation anxiety alone.
| Finding | Reported figure | Population or scope |
|---|---|---|
| Excessive anxiety speaking to a large audience | One third | Community sample |
| Fear of public speaking | 63.9% | 1,135 undergraduates, ages 17–58 |
| Public-speaking fears | 7.3% | 17,615 Japanese adolescents |
| One-year social anxiety disorder prevalence | 7%–8% | Broader disorder estimate |
| Lifetime social anxiety disorder prevalence | 13%–14% | Broader disorder estimate |
When does public-speaking fear begin?
The community-sample study found that public-speaking fears often begin early. Fifty percent of public-speaking fears had begun by age 13. The cumulative proportion rose to 75% by age 17 and 90% by age 20. These are onset milestones reported by that study; they do not establish that presentation anxiety always begins during childhood or adolescence.
The broader social-anxiety literature shows a similar pattern of early onset. Social anxiety disorder reports that about 50% of cases have onset by age 11 and about 80% have onset by age 20. Because these figures describe social anxiety disorder rather than presentation anxiety specifically, they should be used as context for developmental timing rather than as a substitute for public-speaking data.
The adolescent evidence includes the Japanese sample of 17,615 adolescents, in which public-speaking fears were noted in 7.3% of participants. A separate feasibility and pilot study, Virtual reality exposure therapy for adolescents with fear of public speaking: a non-randomized feasibility and pilot study, recruited 27 adolescents aged 13 to 16 years. Together, these studies show why adolescence is an important period for studying presentation fear, while still representing different research questions: one estimated occurrence and the other examined a treatment approach.
What do people fear during a presentation?
The community-sample research measured several specific concerns. The most frequently reported concern in the supplied findings was trembling, shaking, or another visible sign of anxiety: 80% reported this fear. Mind going blank was reported by 74%, while 63% feared being unable to continue talking.
Other fears focused on social judgment and communication. Sixty-four percent feared doing or saying something embarrassing. Fifty-nine percent feared saying foolish things or not making sense. These figures indicate that presentation anxiety can involve both internal performance worries and concern about how an audience will interpret visible or verbal mistakes.
The results describe feared outcomes, not necessarily outcomes that occurred in every presentation. A person may fear going blank without actually losing their train of thought, or fear visible shaking without an audience noticing it. The study’s percentages therefore help describe the content of anxiety rather than predict an individual speaker’s behavior.
How much does anxiety affect daily life?
In the community sample, 10% reported that public-speaking anxiety caused marked interference or marked distress. The study separated several types of impact. Marked interference was reported for work by 2%, social life by 1%, and education by 4%. Marked distress was reported by 8%.
The same study found that 5% had public-speaking anxiety in isolation, without additional social fears. This distinction matters because fear of presentations may occur as a focused problem, or it may appear alongside wider social fears. The finding does not show that isolated presentation anxiety is always milder; it only reports how the study classified the pattern.
These impairment figures are not interchangeable with prevalence figures. One third of respondents reported excessive anxiety when speaking to a large audience, while 10% reported marked interference or marked distress. The difference reflects different thresholds and outcomes: experiencing strong anxiety is not the same as reporting a marked effect on work, education, social life, or overall distress.
What do college-student studies show?
The college-student study reported fear of public speaking in 63.9% of its 1,135 undergraduate participants, whose ages ranged from 17 to 58 years. It also found that 89.3% wanted public-speaking classes included in their undergraduate program. The combination of these figures points to a large perceived need for instruction within that sample, but it does not measure whether such classes reduced anxiety or improved performance.
Another study, Measuring Public Speaking Anxiety: Self-report, behavioral, and physiological, reported anxiety before speaking in three self-report groups: 57% reported high anxiety, 20% moderate anxiety, and 22% lower anxiety. On the PRCA-PS measure, 50% recorded high public-speaking anxiety, 42% moderate anxiety, and 9% low anxiety. The categories do not sum perfectly to 100% because of rounding.
The same study reported a mean speech duration of 7.45 minutes, with a standard deviation of 2.53 minutes. Its mean PRCA-PS score was 20.5, with a standard deviation of 4.75; observed scores ranged from a minimum of 11 to a maximum of 30. A VAS1 measure had a mean score of 5.76 and a standard deviation of 2.64. These values describe the study’s participants and instruments, not a universal presentation-anxiety scale.
How is presentation anxiety measured?
Presentation anxiety research combines self-report, behavioral observations, and physiological measures. In the measurement study, public-speaking anxiety correlated with speech duration at r = -0.31 and with self-perceived speech performance at r = -0.42. In that sample, higher anxiety was associated with shorter speech duration and lower self-perceived performance, but correlation alone does not establish that anxiety caused either result.
Physiological findings were less closely aligned with the PRCA-PS anxiety measure. PRCA-PS did not correlate with skin conductance responses, with r = 0.16, or with heart-rate variability, with r = 0.05. A second heart-rate variability check reported r = 0.02. The study reported a skin conductance response mean change of -0.18 and a standard deviation of 0.48.
These results illustrate why a single number should not be treated as a complete picture of presentation anxiety. A speaker’s questionnaire score, speech behavior, perception of performance, skin conductance, and heart-rate variability may not move together in the same way. Measures can capture different aspects of the experience.
What do intervention studies report?
The Corp-Oral evaluation, Embodied strategies for public speaking anxiety: evaluation of the Corp-Oral program, enrolled 36 students. Sixty-one percent of participants were women. The mean age was 20.22 years, with an age standard deviation of 1.23 years. In that program, self-reported anxiety fell by 33.217%, and heart rate fell by 4.659%.
Those changes are reported outcomes from the Corp-Oral evaluation, not a forecast for every presentation-skills course. The sample was small, and the supplied finding does not establish that the percentage reductions would be identical in a larger or different population.
The adolescent virtual-reality pilot recruited 27 adolescents aged 13 to 16 years and used one 90-minute treatment session. It found a pre-post treatment effect size of Cohen’s d = 1.53. This is a result from a non-randomized feasibility and pilot study, so it should be read as an early treatment signal rather than a definitive estimate of what one session will achieve for all adolescents with fear of public speaking.
Taken together, the intervention findings show that researchers have studied both embodied strategies and virtual-reality exposure, with outcomes reported through self-report, heart rate, and an effect-size statistic. The small samples and differing designs mean that the results are best used to understand the direction and scale of findings in those studies, not to promise a particular response.